 NEWARK, Calif., Dec. 7, 2020 PRNewswire -- Protagonist Therapeutics, Inc. Nasdaq:PTGX today announced the results of a large-scale analysis of real world treatment patterns for polycythemia vera, demonstrating that treatment incorporating existing options failed to achieve hematocrit... 